Hyperspectral imaging in systemic sclerosis-associated Raynaud phenomenon

Abstract Background/purpose Lack of robust, feasible, and quantitative outcomes impedes Raynaud phenomenon (RP) clinical trials in systemic sclerosis (SSc) patients. Hyperspectral imaging (HSI) non-invasively measures oxygenated and deoxygenated hemoglobin (oxyHb and deoxyHb) concentrations and oxyg...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Shannon Teaw, Akash Gupta, Alyssa Williams, F. Perry Wilson, Brandon J. Sumpio, Bauer E. Sumpio, Monique Hinchcliff
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMC 2023-01-01
Edice:	Arthritis Research & Therapy
Témata:	Systemic sclerosis Scleroderma Hyperspectral imaging Raynaud phenomenon Patient-reported outcome instruments Imaging
On-line přístup:	https://doi.org/10.1186/s13075-023-02990-3
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!